Features | Partner Sites | Information | LinkXpress
Sign In
KOREA E & EX
Advantech Europe
Schiller

Remote Presence Robot Extends Patient Care

By HospiMedica International staff writers
Posted on 29 Jan 2013
Image: The RP-VITA remote presence robot (Photo courtesy of InTouch Health).
Image: The RP-VITA remote presence robot (Photo courtesy of InTouch Health).
A new telemedicine robot designed for remote doctor-to-patient consultation combines state-of-the-art telecommunications and autonomous navigation technology.

The RP-VITA is intended for active patient monitoring in preoperative, perioperative, and postsurgical settings, including cardiovascular, neurological, prenatal, psychological, and critical care assessments and examinations. The robot features Auto Drive (an optional advanced autonomous navigation and driving feature) and an iPad user interface that provides versatility and ease of use and for delivering high acuity telemedicine. The RP-VITA robot merges seamlessly with existing hospital processes to provide state-of-the-art audiovisual capabilities with a high-quality interactive experience.

The RP-VITA platform was designed with a full range of clinical capabilities for delivering services such as TeleStroke and TeleICU today that can be expanded to integrate patient data, and enable other important clinical functions in the future. The RP-VITA telemedicine robot is a product of InTouch Health (Santa Barbara, CA, USA), and has been approved by the US Food and Drug Administration (FDA).

“RP-VITA brings to market a true next-generation remote presence solution that will enable many new clinical applications and uses,” said Yulun Wang, PhD, Chairman and CEO of InTouch Health. “We are proud to have achieved this regulatory objective with the autonomous navigation capability for RP-VITA and are absolutely committed to the highest standards for safety and efficacy.”

“RP-VITA raises the bar for acute care telemedicine solutions for patient care delivery. The Robot allows me to effortlessly follow the entire clinical workflow process, and puts me at the point of care precisely when and where I need to be,” said Paul Vespa, MD, director of neurocritical care at the UCLA Health System (Los Angeles, CA, USA). “As a thought-leader in today’s challenging health care environment, we at UCLA are very pleased to have participated in the clinical development and validation of this revolutionary heath care delivery platform.”

Related Links:

InTouch Health
UCLA Health System



Channels

Critical Care

view channel
Image: Repellent surface technology prevents biofilm formation (Photo courtesy of Joanna Aizenberg/ Harvard).

Slippery Surface Technology Repels Bacterial Biofilm

Novel lubricant-infused slippery polymers could serve as a long lasting, self-replenishing solution to repel deadly bacterial build-up in medical devices. Researchers at Harvard University (Cambridge,... Read more

Surgical Techniques

view channel

Nonlinear Acoustic Analysis Could Help Destroy Kidney Stones

Mathematical analysis and simulation of models governing the propagation of sound in fluids could enhance lithotripsy, according to a new study. Researchers at Alpen-Adria-Universität (Klagenfurt am Wörthersee, Austria) are developing an application-oriented comprehensive mathematical analysis of the underlying model... Read more

Women's Health

view channel

Nitrous Oxide for Labor Makes US Comeback

Long used for its anxiolytic properties during labor in European countries and Canada, nitrous oxide (N2O) use is resurging in the United States. While in countries such as Norway, New Zealand, Sweden, Australia, and England, usage rates of inhalational N2O during parturition reach 70%, it has only recently become an... Read more

Business

view channel

Pfizer to Buy Hospira to Bolster Hospital Products

Pfizer (New York, NY, USA) has entered into a definitive merger agreement with Hospira (Lake Forest, IL, USA), in a move designed to significantly enhance their global established pharmaceutical (GEP) business, for a total enterprise value of approximately USD 17 billion. The strategic complementary combination will... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.